415912-70-8 Usage
Uses
Used in Pharmaceutical Industry:
2-Pyridineacetonitrile,4-amino-(9CI) is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new compounds with diverse functionalities, contributing to the discovery of novel drugs with improved therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Pyridineacetonitrile,4-amino-(9CI) serves as a crucial building block in the synthesis of various agrochemicals. Its incorporation into these compounds can enhance their effectiveness in pest control and crop protection, leading to increased agricultural productivity.
Used in Dye and Pigment Production:
2-Pyridineacetonitrile,4-amino-(9CI) is utilized in the production of dyes and pigments due to its ability to impart color to various materials. Its unique chemical structure allows for the creation of a wide range of colors, making it a valuable component in the dye and pigment industry.
Used in Organic Chemistry Research:
As a versatile building block, 2-Pyridineacetonitrile,4-amino-(9CI) has potential applications in the field of organic chemistry research. It can be used to explore new reaction pathways, develop novel synthetic methods, and create new compounds with unique properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 415912-70-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,5,9,1 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 415912-70:
(8*4)+(7*1)+(6*5)+(5*9)+(4*1)+(3*2)+(2*7)+(1*0)=138
138 % 10 = 8
So 415912-70-8 is a valid CAS Registry Number.
415912-70-8Relevant articles and documents
Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
-
Page 102, (2010/02/06)
Methods of treating IL-6 involved diseases with EP4 receptor ligands, including EP4 receptor antagonists. Assays to determine the effect of test compounds on PGE2-induced whole blood cells activation.
EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS
-
, (2008/06/13)
The invention features a method of treating rheumatoid arthritis in a mammal comprising administering an agent that inhibits prostaglandin EP4 receptor (EP4) activity. Also featured is a method of identifying agents that selectively inhibit EP4 activity in vivo.
